ReviewInternational journal of chronic obstructive pulmonary disease2013

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Marc L Decramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.